|
|
||||||||
Clinical Chemistry, Vol 18, 567-568, Copyright © 1972 by the American Association for Clinical Chemistry
1 Clinical Laboratory and Department of Medicine
and Surgery, Stanford University Hospital, Stanford, Calif.
94305.
Glutamic-oxalacetic transaminase (aspartate transaminase) activity is decreased in serum of patients undergoing long-term hemodialysis. The reason may be the repeated dialysis, pyridoxine depletion, or both.
Submitted on February 16, 1972
Accepted on March 13, 1972
The following articles in journals at HighWire Press have cited this article:
![]() |
B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER Recommendations for the Outpatient Surveillance of Renal Transplant Recipients J. Am. Soc. Nephrol., October 1, 2000; 11 (90001): S1 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. CHANG, R. V. BARNES, and F. K. PORT Transaminase Levels in Azotemia Ann Intern Med, August 1, 1976; 85(2): 255 - 256. [Abstract] [PDF] |
||||
![]() |
G. A. COHEN, J. A. GOFFINET, R. K. DONABEDIAN, and H. O. CONN Observations on Decreased Serum Glutamic Oxalacetic Transaminase (SGOT) Activity in Azotemic Patients Ann Intern Med, March 1, 1976; 84(3): 275 - 280. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |